Roxane Wants DOJ Sanctioned For Spoliation

Law360, New York (July 10, 2009, 12:00 AM EDT) -- The U.S. Department of Justice allegedly spoliated evidence in the average wholesale price antitrust litigation that could reduce Boehringer Ingelheim Roxane Inc.'s damages by up to $1 billion, the pharmaceutical company said in a motion for sanctions against the department.

Despite keeping a lawsuit against Roxane sealed for nearly seven years while it conducted its own discovery, the DOJ allegedly failed to ensure that critical evidence survived, the company said in a motion filed Thursday in the U.S. District Court for the District of Massachusetts. Roxane's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.